Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shimoni

Showing results (651-660 of 778) with videos related to

Pageof 78
Sort By:
Infectious Diseases (London, England)|October 4, 2021
High rate of bacterial respiratory tract co-infections upon admission amongst moderate to severe COVID-19 patientsRegev Cohen, Talya Finn, Frida Babushkin, et al.
Oncotarget|June 25, 2020
Reassessing the role of high dose cytarabine and mitoxantrone in relapsed/refractory acute myeloid leukemiaJonathan Canaani, Meital Nagar, Gabriel Heering, et al.
Plos One|March 5, 2016
Prediction of Hematopoietic Stem Cell Transplantation Related Mortality- Lessons Learned from the In-Silico Approach: A European Society for Blood and Marrow Transplantation Acute Leukemia Working Party Data Mining StudyRoni Shouval, Myriam Labopin, Ron Unger, et al.
Cancer|March 23, 2017
Long-term outcome after a treosulfan-based conditioning regimen for patients with acute myeloid leukemia: A report from the Acute Leukemia Working Party of the European Society for Blood and Marrow TransplantationArnon Nagler, Myriam Labopin, Dietrich Beelen, et al.
Nature Chemical Biology|July 15, 2020
Designer protein assemblies with tunable phase diagrams in living cellsMeta Heidenreich, Joseph M Georgeson, Emanuele Locatelli, et al.
British Journal of Haematology|November 17, 2009
Unrelated stem cell transplantation after reduced intensity conditioning for patients with multiple myeloma relapsing after autologous transplantationNicolaus Kröger, Avichai Shimoni, Georgia Schilling, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|September 5, 2012
Pseudomonas aeruginosa serology and risk for re-isolation in the EPIC trialMichael Anstead, Sonya L Heltshe, Umer Khan, et al.
Biotechnology and Bioengineering|April 21, 2015
More similar than different: Host cell protein production using three null CHO cell linesInn H Yuk, Julie Nishihara, Donald Walker, et al.
Oncotarget|November 24, 2016
Immunological effects of nilotinib prophylaxis after allogeneic stem cell transplantation in patients with advanced chronic myeloid leukemia or philadelphia chromosome-positive acute lymphoblastic leukemiaNira Varda-Bloom, Ivetta Danylesko, Roni Shouval, et al.
Bone Marrow Transplantation|December 3, 2020
Immune imitation of tumor progression after anti-CD19 chimeric antigen receptor T cells treatment in aggressive B-cell lymphomaIvetta Danylesko, Roni Shouval, Noga Shem-Tov, et al.
Pageof 78

Showing results (651-660 of 778) with videos related to

Sort By:
Pageof 78
Infectious Diseases (London, England)|October 4, 2021
High rate of bacterial respiratory tract co-infections upon admission amongst moderate to severe COVID-19 patientsRegev Cohen, Talya Finn, Frida Babushkin, et al.
Oncotarget|June 25, 2020
Reassessing the role of high dose cytarabine and mitoxantrone in relapsed/refractory acute myeloid leukemiaJonathan Canaani, Meital Nagar, Gabriel Heering, et al.
Plos One|March 5, 2016
Prediction of Hematopoietic Stem Cell Transplantation Related Mortality- Lessons Learned from the In-Silico Approach: A European Society for Blood and Marrow Transplantation Acute Leukemia Working Party Data Mining StudyRoni Shouval, Myriam Labopin, Ron Unger, et al.
Cancer|March 23, 2017
Long-term outcome after a treosulfan-based conditioning regimen for patients with acute myeloid leukemia: A report from the Acute Leukemia Working Party of the European Society for Blood and Marrow TransplantationArnon Nagler, Myriam Labopin, Dietrich Beelen, et al.
Nature Chemical Biology|July 15, 2020
Designer protein assemblies with tunable phase diagrams in living cellsMeta Heidenreich, Joseph M Georgeson, Emanuele Locatelli, et al.
British Journal of Haematology|November 17, 2009
Unrelated stem cell transplantation after reduced intensity conditioning for patients with multiple myeloma relapsing after autologous transplantationNicolaus Kröger, Avichai Shimoni, Georgia Schilling, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|September 5, 2012
Pseudomonas aeruginosa serology and risk for re-isolation in the EPIC trialMichael Anstead, Sonya L Heltshe, Umer Khan, et al.
Biotechnology and Bioengineering|April 21, 2015
More similar than different: Host cell protein production using three null CHO cell linesInn H Yuk, Julie Nishihara, Donald Walker, et al.
Oncotarget|November 24, 2016
Immunological effects of nilotinib prophylaxis after allogeneic stem cell transplantation in patients with advanced chronic myeloid leukemia or philadelphia chromosome-positive acute lymphoblastic leukemiaNira Varda-Bloom, Ivetta Danylesko, Roni Shouval, et al.
Bone Marrow Transplantation|December 3, 2020
Immune imitation of tumor progression after anti-CD19 chimeric antigen receptor T cells treatment in aggressive B-cell lymphomaIvetta Danylesko, Roni Shouval, Noga Shem-Tov, et al.
Pageof 78